← Leaderboards
Vladimir Rudchenko
Alchem Laboratories Corporation
$3,644,987
Attributed
$3,644,987
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2016–20$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,644,987 · 2
By mechanism
N02$3,644,987 · 2
Top collaborators
No co-investigators on record.
Most similar at Alchem Laboratories Corporation
Same institution · by research overlap
- Sergiy Denysenko$4,015,653
- Emil Pop$2,334,584
- James Talton$3,320,110
- James D Talton$324,540
- Mianji Zhang$97,648
Others in their field
Top investigators on “Drug Development”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$409,188,846
- Lawrence Corey · Fred Hutchinson Cancer Center$302,964,844
- Wafaa M. El-Sadr · Columbia University Health Sciences$291,216,450
- Constance Ann Benson · University Of California, San Diego$284,817,600
Research focus
Drug DevelopmentBiologicalAnalogRecommendationEvaluationProgramsContractsPharmaceutical PreparationsInvestigational TherapiesMalignant NeoplasmsMethodologyMissionChemical SynthesisLiteratureAnalytical ChemistryChemistryCombinatorialDrug DiscoveryFallsFundingLeadLibrariesPharmacodynamicsProcedures
Grant awards (7)
NON-GMP SYNTHESIS OF COMPOUNDS FOR DRUG DEVELOPMENT$627,585
N02 · FY2020 · CA · contact PI
NON-GMP SYNTHESIS OF COMPOUNDS FOR DRUG DEVELOPMENT$503,874
N02 · FY2019 · CA · contact PI
NON-GMP SYNTHESIS OF COMPOUNDS FOR DRUG DEVELOPMENT$549,643
N02 · FY2018 · CA · contact PI
IGF::OT::IGF NON-GMP SYNTHESIS OF COMPOUNDS FOR DRUG DEVELOPMENT$535,826
N02 · FY2017 · CA · contact PI
Synthesis support for early stages of drug discovery and development program$412,782
N02 · FY2017 · CA · contact PI
IGF::OT::IGF NON-GMP SYNTHESIS OF COMPOUNDS FOR DRUG DEVELOPMENT$522,411
N02 · FY2016 · CA · contact PI
OTHER FUNCTIONS TAS::75 0849::TAS; THIS MODIFICATION ADDS FUNDING FOR WA'S 2 AND$492,866
N02 · FY2016 · CA · contact PI